ConductScience.org, home

Paper29313005

Biomimetic strategies for targeted nanoparticle delivery.

Dehaini D and 2 others. Bioeng Transl Med, 2016. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Biomimetic strategies for targeted nanoparticle delivery. Papers, record 29313005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29313005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biomimetic strategies for targeted nanoparticle delivery.
PubMed
Journal
Bioeng Transl Med
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
4.1
iCite
Revised in PubMed
2020-09-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dehaini DDiana
2Fang RHRonnie H
3Zhang LLiangfang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DK095168NIDDK NIH HHSUnited StatesR01DK095168PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References199

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121605902FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells.Biomaterials2011https://conductscience.org/library/papers/21605902PubMed
223241654Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.Nat Nanotechnol2013https://conductscience.org/library/papers/23241654PubMed
311916843Comparison of PSGL-1 microbead and neutrophil rolling: microvillus elongation stabilizes P-selectin bond clusters.Biophys J2002https://conductscience.org/library/papers/11916843PubMed
419279573Microenvironmental regulation of metastasis.Nat Rev Cancer2009https://conductscience.org/library/papers/19279573PubMed
521906806Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery.Biomaterials2011https://conductscience.org/library/papers/21906806PubMed
623850793Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.Int J Pharm2013https://conductscience.org/library/papers/23850793PubMed
724531078Targeted therapy using nanotechnology: focus on cancer.Int J Nanomedicine2014https://conductscience.org/library/papers/24531078PubMed
819447208Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.Nanomedicine2010https://conductscience.org/library/papers/19447208PubMed
91388654The origin and function of tumor-associated macrophages.Immunol Today1992https://conductscience.org/library/papers/1388654PubMed
1010090858Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium.Microb Pathog1999https://conductscience.org/library/papers/10090858PubMed
1119735683Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.J Control Release2010https://conductscience.org/library/papers/19735683PubMed
1215560977Virus-like particles as vaccines and vessels for the delivery of small molecules.Curr Opin Biotechnol2004https://conductscience.org/library/papers/15560977PubMed
1318041638M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.J Drug Target2007https://conductscience.org/library/papers/18041638PubMed
1416051391Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate.J Control Release2005https://conductscience.org/library/papers/16051391PubMed
1522901307Detection and isolation of dendritic cells using Lewis X-functionalized magnetic nanoparticles.Biomacromolecules2012https://conductscience.org/library/papers/22901307PubMed
1626519648Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.Biomaterials2016https://conductscience.org/library/papers/26519648PubMed
1716476163Canine parvovirus-like particles, a novel nanomaterial for tumor targeting.J Nanobiotechnology2006https://conductscience.org/library/papers/16476163PubMed
1816497584Virus entry: open sesame.Cell2006https://conductscience.org/library/papers/16497584PubMed
1924280870Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.Nanoscale2014https://conductscience.org/library/papers/24280870PubMed
2022138068Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery.J Control Release2012https://conductscience.org/library/papers/22138068PubMed

See all 199 referencesDownload CSV of references

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
42794948Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges.Cancers (Basel)2026https://conductscience.org/library/papers/42794948PubMed
42277942Targeting mRNA delivery using bio-inspired hybrid cell membrane-incorporated liposomes: a novel strategy for cancer therapy.Biomark Res2026https://conductscience.org/library/papers/42277942PubMed
42198228Advances of Cell Membrane-Coated Nanotechnology and Membrane Vesicles in Intestinal Targeted Drug Delivery Systems.Pharmaceutics2026https://conductscience.org/library/papers/42198228PubMed
42010558mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges.J Nanobiotechnology2026https://conductscience.org/library/papers/42010558PubMed
41244334Biosynthetic blood surrogates: Current status and future opportunities.Bioeng Transl Med2025https://conductscience.org/library/papers/41244334PubMed
40948582Synergistic HER2-scFv mediated immunotherapy with targeted gemcitabine delivery harnessing biomimetic composite nanoparticles for enhanced metastatic tumor therapy.Mater Today Bio2025https://conductscience.org/library/papers/40948582PubMed
40943069Cell-Based Drug Delivery Systems: Innovative Drug Transporters for Targeted Therapy.Int J Mol Sci2025https://conductscience.org/library/papers/40943069PubMed
40673130Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases.Mater Today Bio2025https://conductscience.org/library/papers/40673130PubMed
39883380The modification of conventional liposomes for targeted antimicrobial delivery to treat infectious diseases.Discov Nano2025https://conductscience.org/library/papers/39883380PubMed
39806939Organelle-Targeting Nanoparticles.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39806939PubMed
39795966RNA Structure: Past, Future, and Gene Therapy Applications.Int J Mol Sci2024https://conductscience.org/library/papers/39795966PubMed
39769486Cell Membrane- and Extracellular Vesicle-Coated Chitosan Methacrylate-Tripolyphosphate Nanoparticles for RNA Delivery.Int J Mol Sci2024https://conductscience.org/library/papers/39769486PubMed
39722148Microfluidics-Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle-Vesicle Hybrids.Adv Healthc Mater2025https://conductscience.org/library/papers/39722148PubMed
39113804Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries.Theranostics2024https://conductscience.org/library/papers/39113804PubMed
37849681Design Strategies for Cellular Nanosponges as Medical Countermeasures.BME Front2023https://conductscience.org/library/papers/37849681PubMed
37789955Lipid-based nanoparticles for cancer immunotherapy.Med Rev (2021)2023https://conductscience.org/library/papers/37789955PubMed
37763873A Review of Single-Cell Microrobots: Classification, Driving Methods and Applications.Micromachines (Basel)2023https://conductscience.org/library/papers/37763873PubMed
37724085Versatile biomimetic nanomedicine for treating cancer and inflammation disease.Med Rev (2021)2023https://conductscience.org/library/papers/37724085PubMed
37687260
Exploring the Biomedical Applications of Biosynthesized Silver Nanoparticles Using Perilla frutescens Flavonoid Extract: Antibacterial, Antioxidant, and Cell Toxicity Properties against Colon Cancer Cells.
Molecules2023https://conductscience.org/library/papers/37687260PubMed
37592345Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis.J Nanobiotechnology2023https://conductscience.org/library/papers/37592345PubMed

See all 76 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29313005

GET https://conductscience.org/api/papers/v1/29313005/references?page=2